-
Evaluating the Impact of International Drug Pricing Strategies on Indian State-Level
Sep 9, 2025, 16:22 PM -
Digital Twins: Hype or Hope for Better Health Outcomes
Sep 9, 2025, 16:22 PM -
Impact of Nonclinically Driven Inhaler Initiation or Switch on Carbon (CO2) Emissions and Healthcare Costs for COPD Patients Using Single-Inhaler Triple Therapy (SITT)
Sep 9, 2025, 16:22 PM -
Dupilumab Improves Lung Function and Asthma Control While Reducing Systemic Corticosteroid Use in Patients With Allergic Bronchopulmonary Aspergillosis: The Phase 2 LIBERTY ABPA AIRED Study
Sep 9, 2025, 16:22 PM -
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology
Sep 9, 2025, 16:22 PM -
A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Greece: Proposal for a Medicines Innovation Fund
Sep 9, 2025, 16:22 PM -
Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)
Sep 9, 2025, 16:22 PM -
Mapping the Rare Disease Diagnostic Odyssey of Today: An Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
Concordance Between Patient and Physician Reporting of Symptoms for Metastatic Urothelial Cancer in Europe: A Real-World Survey
Sep 9, 2025, 16:22 PM -
A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk
Sep 9, 2025, 16:22 PM -
Impact of the Societal Perspective on HTA Decision Making in Rare Diseases
Sep 9, 2025, 16:22 PM -
Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns and Outcomes in First-Line Small-Cell Lung Cancer (SCLC) in France
Sep 9, 2025, 16:22 PM -
Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures
Sep 9, 2025, 16:22 PM -
Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France
Sep 9, 2025, 16:22 PM -
Budget and Time Impact Analysis of Introducing Subcutaneous Pembrolizumab to Patients From Institution HCP and Patient Perspectives in the United States (US)
Sep 9, 2025, 16:22 PM -
Estimand Framework in the Setting of Observational Studies: Current Landscape and Future Directions
Sep 9, 2025, 16:22 PM -
Describing the Burden of RSV Infection and Subsequent Wheezing in Toddlers: An International Cross-Sectional Study
Sep 9, 2025, 16:22 PM -
Disease-Free Survival as a Surrogate Endpoint for Overall Survival in Patients With Adjuvant Treatments for Completely Resected Stage I-III Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Firstline Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review With Focus on the PD-L1 Negative Subgroup
Sep 9, 2025, 16:22 PM
